
Sanjeeve Balasubramaniam MD MPH
Endocrine Cancer, Gynecologic Cancer, Hematologic Oncology
Clinical Team Lead, Gyn Onc and Rad Onc, Office of Hematology and Oncology Products, US FDA
Join to View Full Profile
10903 New Hampshire AveSilver Spring, MD 20993
Phone+1 240-402-4975
Dr. Balasubramaniam is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 2006 - 2011
- MedStar Health Georgetown University/Georgetown HospitalResidency, Internal Medicine, 2003 - 2006
- SSM Health/Saint Louis University School of MedicineResidency, Surgery, 1998 - 2002
- SUNY Upstate Medical UniversityClass of 1998
Certifications & Licensure
- DC State Medical License 2003 - 2022
Publications & Presentations
PubMed
- 111 citationsFDA Approval Summary: Olaparib Monotherapy or in Combination with Bevacizumab for the Maintenance Treatment of Patients with Advanced Ovarian Cancer.Shaily Arora, Sanjeeve Balasubramaniam, Hui Zhang, Tara Berman, Preeti Narayan
The Oncologist. 2021-01-01 - 65 citationsFDA Approval Summary: Pembrolizumab plus Lenvatinib for Endometrial Carcinoma, a Collaborative International Review under Project OrbisShaily Arora, Sanjeeve Balasubramaniam, Wei Zhang, Lijun Zhang, Rajeshwari Sridhara
Clinical Cancer Research. 2020-10-01 - 13 citationsPhase I/II Trial of Vandetanib and Bortezomib in Adults with Locally Advanced or Metastatic Medullary Thyroid CancerJaydira Del Rivero, Maureen Edgerly, Jean Ward, Ravi A. Madan, Sanjeeve Balasubramaniam
The Oncologist. 2019-01-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: